Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Zai Lab Ltd ADR (ZLAB)

Zai Lab Ltd ADR (ZLAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,858,704
  • Shares Outstanding, K 99,609
  • Annual Sales, $ 266,720 K
  • Annual Income, $ -334,620 K
  • 60-Month Beta 1.06
  • Price/Sales 7.02
  • Price/Cash Flow N/A
  • Price/Book 2.45
Trade ZLAB with:

Options Overview Details

View History
  • Implied Volatility 80.67% ( +8.01%)
  • Historical Volatility 39.57%
  • IV Percentile 78%
  • IV Rank 55.97%
  • IV High 127.18% on 06/17/24
  • IV Low 21.54% on 12/18/23
  • Put/Call Vol Ratio 0.22
  • Today's Volume 311
  • Volume Avg (30-Day) 303
  • Put/Call OI Ratio 4.12
  • Today's Open Interest 9,347
  • Open Int (30-Day) 11,569

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate -0.66
  • Number of Estimates 3
  • High Estimate -0.59
  • Low Estimate -0.77
  • Prior Year -1.25
  • Growth Rate Est. (year over year) +47.20%

Price Performance

See More
Period Period Low Period High Performance
1-Month
16.20 +21.60%
on 07/09/24
20.15 -2.23%
on 07/22/24
+1.13 (+6.09%)
since 06/21/24
3-Month
15.00 +31.33%
on 04/23/24
22.35 -11.86%
on 05/13/24
+4.71 (+31.42%)
since 04/22/24
52-Week
13.48 +46.14%
on 04/18/24
32.60 -39.57%
on 07/28/23
-9.92 (-33.49%)
since 07/21/23

Most Recent Stories

More News
Fight Against Pancreatic Cancer Ramps Up as Market Size Revenues Expected to Exceed $36 Billion by 2036

EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:ZLAB),(NASDAQ:NTBL),(NASDAQ:CRDF),(NYSE:JNJ) EQNX::TICKER_END

ONCY : 1.0200 (-0.97%)
ONC.TO : 1.42 (+0.71%)
ZLAB : 19.70 (+5.57%)
NTBL : 0.6800 (-5.56%)
CRDF : 2.35 (+4.44%)
JNJ : 154.24 (-0.29%)
Why Wall Street Thinks This Artificial Intelligence (AI) Stock Could Skyrocket 140% Over the Next 12 Months

Cathie Wood and Bill Gates like this stock, too.

ZLAB : 19.70 (+5.57%)
ARKG : 26.24 (+3.39%)
SDGR : 23.21 (+8.61%)
Qiming Venture Partners' portfolio company Tuhu Car Successfully Listed on the Hong Kong Stock Exchange

/PRNewswire/ -- Qiming Venture Partners' portfolio company Tuhu Car, China's leading one-stop car service platform, successfully listed on the Hong Kong Stock...

BILI : 15.35 (+2.06%)
ZH : 3.27 (-2.10%)
ZLAB : 19.70 (+5.57%)
SDGR : 23.21 (+8.61%)
Why Shares of Zai Lab Limited Were Jumping on Tuesday

Zai Lab's shares benefited from positive clinical trial news.

ZLAB : 19.70 (+5.57%)
SGEN : 228.74 (-0.07%)
GMAB : 27.80 (+0.18%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zai Lab Limited - ZLAB

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Zai Lab Limited ("Zai Lab" or the "Company") (NASDAQ: ZLAB). Such investors are...

ZLAB : 19.70 (+5.57%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zai Lab Limited - ZLAB

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Zai Lab Limited ("Zai Lab" or the "Company") (NASDAQ: ZLAB). Such investors are...

ZLAB : 19.70 (+5.57%)
ROSEN, A TOP RANKED LAW FIRM, Encourages Zai Lab Limited Investors to Inquire About Securities Class Action Investigation - ZLAB

/PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of...

ZLAB : 19.70 (+5.57%)
ZLAB ALERT: The Law Offices of Vincent Wong Investigate Zai Lab Limited for Potential Violations of Securities Laws

/PRNewswire/ -- Attention Zai Lab Limited ("Zai Lab") (NASDAQ: ZLAB) shareholders: The Law Offices of Vincent Wong announce that an investigation has commenced...

ZLAB : 19.70 (+5.57%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zai Lab Limited - ZLAB

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Zai Lab Limited ("Zai Lab" or the "Company") (NASDAQ: ZLAB). Such investors are...

ZLAB : 19.70 (+5.57%)
ZLAB INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Involving Possible Securities Fraud Violations by Officers of Zai Lab Limited

/PRNewswire/ -- Levi & Korsinsky notifies investors that it has commenced an investigation of Zai Lab Limited ("Zai Lab") (NASDAQ: ZLAB) concerning possible...

ZLAB : 19.70 (+5.57%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 16% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Zai Lab Ltd is a biopharmaceutical company. It focused on medicines for cancer, autoimmune and infectious diseases primarily in China. The company's product pipeline consists of ZL-2306, ZL-2401, ZL-2301, ZL-3101, ZL-2302 and ZL-1101 which are in clinical stage. Zai Lab Ltd is based in Pudong, China....

See More

Key Turning Points

3rd Resistance Point 19.60
2nd Resistance Point 19.19
1st Resistance Point 18.92
Last Price 19.70
1st Support Level 18.24
2nd Support Level 17.83
3rd Support Level 17.56

See More

52-Week High 32.60
Fibonacci 61.8% 25.30
Fibonacci 50% 23.04
Fibonacci 38.2% 20.78
Last Price 19.70
52-Week Low 13.48

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar